Aldafermin Completed Phase 2 Trials for Primary Biliary Cholangitis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02135536Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis
NCT02026401Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis